2024
- LATEST
- 2023
- 2022
- 2021
- ARCHIVE
-
34th Ordinary General Meeting of Shareholders
-
FY2023 Financial Results Presentation
-
42nd Annual J.P. Morgan Healthcare Conference
-
Jefferies London Healthcare Conference 2023
-
R&D Day
-
H1 FY2023 Financial Results
-
Acquisition of Idorsia’s Pharmaceuticals Business in Japan and APAC (ex China)
-
33rd Ordinary General Meeting of Shareholders
-
Top Interview - Stock Voice TV (Japanese only)
-
FY2022 Financial Results Presentation
-
41st J.P. Morgan Healthcare Conference
-
Jefferies London Healthcare Conference
-
IR seminar for individual investors (Japanese only) - Sosei's Business Overview
-
R&D Day
-
IR seminar for individual investors (Japanese only) - Intrroduction for Biotechnology Sector
-
H1 FY2022 Financial Results Presentation
-
32nd Ordinary General Meeting of Shareholders
-
FY2021 Financial Results Presentation
-
40th Annual J.P. Morgan Healthcare Conference
-
Jefferies London Healthcare Conference
-
IR seminar for individual investors (Japanese only) - Sosei's Business Overview
-
R&D Day
-
IR seminar for individual investors (Japanese only) - Intrroduction for Biotechnology Sector
-
H1 FY2022 Financial Results Presentation
-
32nd Ordinary General Meeting of Shareholders
-
FY2021 Financial Results Presentation
-
40th Annual J.P. Morgan Healthcare Conference
-
Coronavirus Program Update
-
H1 FY2020 Financial Results Presentation
-
New Discovery Collaboration With AbbVie (Japanese only)
-
30th Ordinary General Meeting of Shareholders
-
FY2019 Financial Results Presentation
-
38th Annual J.P. Morgan Healthcare Conference
-
Investor R&D Day Presentation - Malcolm Weir, EVP Chief R&D Officer
-
Investor R&D Day Presentation - Chris de Graaf Director, Head of Computational Chemistry
-
Investor R&D Day Presentation - Stacey Southall Associate Director, Head of Biophysics
-
Investor R&D Day Presentation - Rie Suzuki - Director, Translational Sciences
-
Investor R&D Day Presentation - Professor Yoshinori Fujiyoshi (Japanese Only)
-
Investor R&D Day Webcast
-
H1 FY2019 Financial Results Presentation
-
Individual Shareholders Briefing (Japanese only)
-
29th Ordinary General Meeting of Shareholders
-
Individual Shareholders Briefing (Japanese only)
-
FY2018 Financial Results (Nine-month period ended December 31, 2018) Presentation (with note)
-
FY2018 Financial Results (Nine-month period ended December 31, 2018) Presentation
-
New collaboration deal with Medicxi
-
37th Annual J.P. Morgan Healthcare Conference (Presentation Transcript)
-
FY2018 Q2 Results Presentation (with note)
-
FY2018 Q2 Results Presentation
-
Update on development activities with HTL0018318
-
28th Ordinary General Meeting of Shareholders
-
2018 UBS Global Healthcare Conference
-
Corporate Profile Full Year Ended 31 Mar 2018
-
FY2017 Full Year Results Presentation
-
2018 Investor Day WEBCAST Opening Remarks by Peter Bains, CEO
-
2018 Investor Day WEBCAST, Pipeline Update by Dr Malcolm Weir, Chief R&D Officer
-
2018 Investor Day WEBCAST, HTL0018318 for DLB in Japan by Dr Tim Tasker, CMO
-
Corporate Profile Half Year Ended 30 Sep 2017
-
36th Annual J.P. Morgan Healthcare Conference
-
FY2017 Q2 Results Presentation
-
Corporate Presentation July 2017
-
27th Ordinary General Meeting of Shareholders
-
Individual Investor Day 2017
-
FY2016 Full Year Results Presentation
-
FY2016 Q2 Results Presentation
-
26th Ordinary General Meeting of Shareholders
-
FY2015 Full Year Results Presentation
-
FY2015 Q2 Results Presentation
-
R&D Day Presentation
-
Investor Day Presentation
-
FY2014 Results Presentation